These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Subchronic haloperidol treatment decreases the in vivo release of tachykinins in rat substantia nigra.
    Author: Lindefors N, Brodin E, Ungerstedt U.
    Journal: Eur J Pharmacol; 1989 Feb 14; 161(1):95-8. PubMed ID: 2470596.
    Abstract:
    Microdialysis combined with sensitive radioimmunoassays was used to measure the in vivo release of substance P (SP) and neurokinin A (NKA) in the rat substantia nigra. The effect of acute and subchronic haloperidol treatment (0.5 mg/kg) on the basal and potassium-evoked release was studied. No significant effect was observed after a single injection. However, pretreatment with haloperidol for 10 days decreased the potassium-induced release of SP and NKA by 25 and 27%, respectively. The basal overflow of NKA was reduced by 29%, while no significant effect could be seen on the basal release of SP.
    [Abstract] [Full Text] [Related] [New Search]